ArticleToxicology and applied pharmacology2022

Non-clinical safety assessment and in vivo biodistribution of CoviFab, an RBD-specific F(ab')2 fragment derived from equine polyclonal antibodies.

Facundo Salinas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.